Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Shareholders??? Equity (Tables)

v3.22.1
Shareholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2021
Stockholders' Equity Note [Abstract]  
Schedule of fair value of options granted was estimated using the Black-Scholes option pricing model
    For the
year ended
December 31,
  For the
year ended
December 31,
    2021   2020
Exercise price   $1.69 - $8.75   $1.56 - $1.77
Expected volatility   89.8% - 96.1%   88.77% - 90.84%
Risk-free interest   0.67% - 1.02%   0.4% - 0.46%
Expected life of up to (years)   6.22   6.2

 

Schedule of option activity
    Number of
Share
Options
    Weighted
Average
Exercise
Price Per
Share
    Weighted
Average
Remaining
Contractual
Term
(in years)
 
Balance as of January 1, 2020     1,272,615     $ 1.52          
Granted     370,351     $ 1.60      
 
 
Expired     (35,788 )   $ 1.60      
 
 
Forfeited     137,667 )   $ 1.68      
 
 
Exercised     (13,750 )   $ 0.88      
 
 
Balance as of December 31, 2020     1,455,761     $ 1.68       7.69  
Granted     108,929     $ 2.02          
Expired     (13,875 )   $ 2.94          
Forfeited     (24,635 )   $ 1.85          
Exercised     (189,700 )   $ 2.06          
Balance as of December 31, 2021     1,336,480     $ 1.64       7.03  
Exercisable at the end of year     858,994     $ 1.55       6.36  

 

Schedule of share-based compensation the Company recognized for share-based payments
    Year ended
December 31,
    Year ended
December 31,
 
    2021     2020  
Cost of revenues     15       16  
Sales and marketing     15       26  
Research and development     109       67  
General and administrative     177       120  
      316       229